Back to Results
First PageMeta Content
Pharmacology / Carbamates / Fixed dose combination / Organofluorides / Antiretroviral drug / Lopinavir/ritonavir / Reverse-transcriptase inhibitor / Zidovudine / Lamivudine / Chemistry / Protease inhibitors / Organic chemistry


Lopinavir/ritonavir M01-384 Abbreviated Clinical Study Report R&D[removed]
Add to Reading List

Document Date: 2014-12-18 16:27:55

Open Document

File Size: 47,48 KB

Share Result on Facebook

Company

3TC/ZDV / SQV / Cox / Abbott Laboratories / Alteon Inc. / /

Country

Canada / /

Event

FDA Phase / /

IndustryTerm

treatment / dual-energy x-ray absorptiometry / treatment groups / /

MedicalCondition

syncope / vomiting / insulin resistance / asymmetric bilateral gynecomastia / progressive multifocal leukoencephalopathy / nutritional disorders / nutritional disorder / diarrhea / infection / hypokalemia / nausea / positive hepatitis C / cardiovascular disease / hepatitis B / dehydration / /

MedicalTreatment

antiretroviral treatment / /

Position

investigator / Infected Subjects Coordinating Investigator / /

Product

Invirase / Combivir / Zidovudine / Lamivudine / Kaletra / HIV-1 / M01-384 / /

PublishedMedium

Baseline / /

Technology

pharmacokinetics / x-ray / /

SocialTag